Connection

Michal Mandelboim to Israel

Back to Details
This is a "connection" page, showing publications Michal Mandelboim has written about Israel.
Michal Mandelboim
Connection Strength
1.010
Israel
  1. Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel. Euro Surveill. 2021 07; 26(26).
    View in: PubMed
    Score: 0.118
  2. Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel. PLoS One. 2021; 16(3):e0243265.
    View in: PubMed
    Score: 0.116
  3. Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory. Viruses. 2020 08 05; 12(8).
    View in: PubMed
    Score: 0.111
  4. Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1. Viruses. 2018 09 21; 10(10).
    View in: PubMed
    Score: 0.097
  5. Exceptional influenza morbidity in summer season of 2017 in Israel may predict the vaccine efficiency in the coming winter. Vaccine. 2018 03 07; 36(11):1326-1329.
    View in: PubMed
    Score: 0.094
  6. Genetic divergence of Influenza A(H3N2) amino acid substitutions mark the beginning of the 2016-2017 winter season in Israel. J Clin Virol. 2017 08; 93:71-75.
    View in: PubMed
    Score: 0.089
  7. A(H1N1)pdm09 influenza infection: vaccine inefficiency. Oncotarget. 2017 May 16; 8(20):32856-32863.
    View in: PubMed
    Score: 0.088
  8. Influenza A(H1N1)pdm 2009 and influenza B virus co-infection in hospitalized and non-hospitalized patients during the 2015-2016 epidemic season in Israel. J Clin Virol. 2017 03; 88:12-16.
    View in: PubMed
    Score: 0.086
  9. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med. 2021 10 14; 385(16):1474-1484.
    View in: PubMed
    Score: 0.030
  10. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med. 2021 09; 9(9):999-1009.
    View in: PubMed
    Score: 0.029
  11. Absence of in-flight transmission of SARS-CoV-2 likely due to use of face masks on board. J Travel Med. 2020 12 23; 27(8).
    View in: PubMed
    Score: 0.028
  12. Characteristics of Clinically Asymptomatic Patients with SARS-CoV-2 Infections, Case Series. Prehosp Disaster Med. 2021 Feb; 36(1):125-128.
    View in: PubMed
    Score: 0.028
  13. Intensive Care Admissions and Associated Severity of Influenza B Versus A During Influenza B Vaccine-mismatched Seasons. Clin Infect Dis. 2019 08 30; 69(6):1049-1052.
    View in: PubMed
    Score: 0.026
  14. Characterization of human parainfluenza virus-3 circulating in Israel, 2012-2015. J Clin Virol. 2018 10; 107:19-24.
    View in: PubMed
    Score: 0.024
  15. Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis. Clin Infect Dis. 2018 04 17; 66(9):1383-1391.
    View in: PubMed
    Score: 0.024
  16. Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16. Euro Surveill. 2018 02; 23(7).
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.